Back to top
more

Alphatec (ATEC)

(Delayed Data from NSDQ)

$13.77 USD

13.77
12,996,487

+3.19 (30.15%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $13.76 -0.01 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Repro Med Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 16.67% and 4.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Strength Seen in Alphatec (ATEC): Can Its 12.1% Jump Turn into More Strength?

by Zacks Equity Research

Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

LENSAR, Inc. (LNSR) Moves 13.5% Higher: Will This Strength Last?

by Zacks Equity Research

LENSAR, Inc. (LNSR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Zacks Equity Research

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alphatec (ATEC) delivered earnings and revenue surprises of -29.03% and 0.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Orthofix (OFIX) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Orthofix (OFIX) delivered earnings and revenue surprises of 107.69% and 0.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ViewRay (VRAY) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

ViewRay (VRAY) delivered earnings and revenue surprises of -6.67% and 2.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Nevro (NVRO) delivered earnings and revenue surprises of 0% and 0.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Idexx Laboratories (IDXX) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Idexx (IDXX) delivered earnings and revenue surprises of 13.17% and 2.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Alphatec (ATEC) Moves 12.8% Higher: Will This Strength Last?

by Zacks Equity Research

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alphatec (ATEC) delivered earnings and revenue surprises of -86.96% and 2.37%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Alphatec (ATEC) Q3 Earnings Expected to Decline

by Zacks Equity Research

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

New Strong Sell Stocks for October 20th

by Zacks Equity Research

GEL, WWD, IBIO, SI, and ATEC have been added to the Zacks Rank #5 (Strong Sell) List on October 20, 2021.

Zacks Equity Research

Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alphatec (ATEC) delivered earnings and revenue surprises of -50.00% and 21.58%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Alphatec (ATEC) Q2 Earnings Expected to Decline

by Zacks Equity Research

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

New Strong Sell Stocks for July 15th

by Zacks Equity Research

ATEC, DRNA, AG, PAX, and AUPH have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2021

Zacks Equity Research

Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alphatec (ATEC) delivered earnings and revenue surprises of 15.79% and 0.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Alphatec (ATEC) Surges 11.4%: Is This an Indication of Further Gains?

by Zacks Equity Research

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alphatec (ATEC) delivered earnings and revenue surprises of 4.35% and 0.19%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OPKO Health's (OPK) BioReference Extends Digital Health Access

by Zacks Equity Research

OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.

Zacks Equity Research

Zacks.com featured highlights include: Alphatec, Fidus Investment and Blue Bird Corp

by Zacks Equity Research

Zacks.com featured highlights include: Alphatec, Fidus Investment and Blue Bird Corp

Nitish Marwah headshot

4 Affordable Breakout Stocks for Stunning Returns

by Nitish Marwah

Selecting breakout stocks continues to be one of the most popular methods utilized by active investors.

Tirthankar Chakraborty headshot

3 Stocks to Watch Out for Earnings Acceleration in 2021

by Tirthankar Chakraborty

It's prudent for investors to keep an eye on a few stocks like Alphatec Holdings (ATEC), Fidus Investment (FDUS) and Blue Bird (BLBD) for stellar earnings acceleration.

Anindya Barman headshot

5 Little-Known Stocks Under $20 Analysts Recommend Buying

by Anindya Barman

We recommend a few lesser-known stocks that hold promise for high returns this year. ADTN, AMEH, ATEC, DFIN and DGII fit the bill.

Zacks Equity Research

Analysts Estimate Alphatec (ATEC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Earnings Preview: Alphatec (ATEC) Q3 Earnings Expected to Decline

by Zacks Equity Research

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.